6533b821fe1ef96bd127abfc

RESEARCH PRODUCT

Mitochondria, the NLRP3 Inflammasome, and Sirtuins in Type 2 Diabetes: New Therapeutic TargetsReviewing Editors:Markus Bachschmid, Dylan Burger, Vittorio Calabrese, Amadou Camara, Lukas Kubala, Giuseppe Poli, and Chandan K. Sen

Celia BañulsSusana Rovira-llopisVictor M. VictorJordi MuntanéMilagros RochaNadezda Apostolova

subject

0301 basic medicineendocrine system diseasesPhysiologyClinical BiochemistryType 2 diabetesMitochondrionBioinformaticsmedicine.disease_causeBiochemistry03 medical and health sciencesMedicineMolecular BiologyGeneral Environmental Sciencebusiness.industryfungifood and beveragesnutritional and metabolic diseasesType 2 Diabetes MellitusInflammasomeCell Biologymedicine.disease030104 developmental biologyGeneral Earth and Planetary SciencesbusinessOxidative stressmedicine.drug

description

Abstract Significance: Type 2 diabetes mellitus and hyperglycemia can lead to the development of comorbidities such as atherosclerosis and microvascular/macrovascular complications. Both type 2 dia...

https://doi.org/10.1089/ars.2017.7313